Iris Atrophy in Sickle Cell Disease.
Di Meglio L, Scott A.
N Engl J Med. 2022 Apr 28;386(17):1646. doi: 10.1056/NEJMicm2117234.
Bilateral Iris Atrophy in a Patient With Parkinsonism.
Ramatchandirane B, Rebello A, Syamala DD, Ganne P, Rodrigues AM.
Neurology. 2023 Nov 14;101(20):910-911. doi: 10.1212/WNL.0000000000207743. Epub 2023 Aug 30.
Iris Atrophy After Administration of Intracameral Dexycu in Routine Cataract Surgery: A Case Series.
Bergman Z, Thompson R, Malouf A, Swamy R.
Eye Contact Lens. 2022 Apr 1;48(4):185-187. doi: 10.1097/ICL.0000000000000873.
Iris atrophy with hypoperfusion and microneovascularisation.
Brooks AM, Gillies WE.
Br J Ophthalmol. 1987 Sep;71(9):706-15. doi: 10.1136/bjo.71.9.706.
Iris alterations after DSAEK.
Del Hierro Zarzuelo A, Boto de Los Bueis A.
Arch Soc Esp Oftalmol. 2016 Sep;91(9):422-5. doi: 10.1016/j.oftal.2016.02.005. Epub 2016 Mar 17.
Iris atrophy in sickle cell disease.
Acheson RW, Ford SM, Maude GH, Lyness RW, Serjeant GR.
Br J Ophthalmol. 1986 Jul;70(7):516-21. doi: 10.1136/bjo.70.7.516.
Iris Manifestations in Inadequately Treated Chronic Recurrent Vogt-Koyanagi-Harada Disease.
Chee SP, Win MZA.
Ocul Immunol Inflamm. 2022 Jul;30(5):1116-1122. doi: 10.1080/09273948.2020.1870701. Epub 2021 Feb 9.
Iridocorneal Endothelial Syndrome: Case Report of Essential Progressive Iris Atrophy.
Beganovic AP, Vodencarevic AN, Halilbasic M, Medjedovic A.
Med Arch. 2022 Jun;76(3):224-228. doi: 10.5455/medarh.2022.76.224-228.
Bilateral acute anterior uveitis and iris atrophy caused by moxifloxacin.
Hui BTK, Capewell N, Ansari Y, Liu X.
BMJ Case Rep. 2020 Jun 30;13(6):e233528. doi: 10.1136/bcr-2019-233528.
Iris atrophy following intracameral dexamethasone injection: a report of two pediatric cases.
Nguyen BM, Do CL, Boydstun IP, Wall PB.
J AAPOS. 2024 Jun;28(3):103901. doi: 10.1016/j.jaapos.2024.103901. Epub 2024 Mar 25.
